Burning Rock Biotech Limited - American Depositary Shares (BNR) closed at $12.90 on October 16, 2026, down 17.3% from the previous close, on volume of 24,911 shares (30-day average 54,019).
Data as of October 16, 2026.
No headlines found.
Burning Rock Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 10-Sep 7:17 AM ET)
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Burning Rock Biotech Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol BNR.
As of October 16, 2026, BNR stock price declined to $12.90 with 24,911 million shares trading.
BNR has a beta of 3.15, meaning it tends to be more sensitive to market movements. BNR has a correlation of 0.09 to the broad based SPY ETF.
BNR has a market cap of $136.05 million. This is considered a Micro Cap stock.
In the last 3 years, BNR traded as high as $41.72 and as low as $2.18.
BNR has outperformed the market in the last year with a return of +60.6%, while the SPY ETF gained +16.7%. In the last 3 month period, BNR beat the market returning +34.3%, while SPY returned +1.9%. However, in the most recent 2 weeks BNR has underperformed the stock market by returning -20.6%, while SPY returned -0.8%.
BNR support price is $14.16 and resistance is $17.04 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNR shares will trade within this expected range on the day.
